Y-29794 (12.5-50 mg/kg, i.p. daily, 5 times a week for 5 weeks) exhibits antitumor efficacy against triple-negative breast cancer in NOD-SCID mice models, without significant toxicity[1].
| Animal Model: | TNBC xenograft NOD-SCID mice model[1] |
| Dosage: | 12.5-50 mg/kg |
| Administration: | i.p., daily, 5 times a week for 5 weeks |
| Result: | Inhibited tumor growth, maintained body weight. |
